Labopharm Receives Complete Response Letter From The U.S. FDA For Novel Antidepressant

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for the new drug application (NDA) submission of its novel formulation of the antidepressant trazodone.
generic viagra online

New Study Results Verify That PNH Cells Are Found In Majority Of Patients With Bone Marrow Failure Syndromes

Paroxysmal nocturnal hemoglobinuria (PNH) cells are present in the majority of patients with myelodysplastic syndromes (MDS), aplastic anemia (AA), and other bone marrow failure syndromes (BMF), according to interim results from 5,285 patients enrolled in the EXPLORE trial. EXPLORE (EXamination of PNH, by Level Of CD59 on REd and white blood cells) is the first large multicenter study to determine the frequency of PNH cells in these patient populations using a central laboratory conducting a high sensitivity test for PNH cells. The findings from EXPLORE will be presented tomorrow at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO). The EXPLORE trial was sponsored by Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN).

News of the day

The Obama Administration Ramps Up Push For Health Care Reform

The Obama administration ramps up efforts to promote health care reform and reacts to a sobering announcement by the Congressional Budget Office about the scoring of a health care bill.

Mental Health

Sanofi Pasteur Responds To Nation's Need For Hib Vaccine With Increased Supply

required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements. Sanofi Pasteur

Pages: 1 [2]

Name:
Site address:	http://
Your message:
Enter today\\\\'s date, 2 digits (spam protection):